Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI. Here's What You Need to Know
December 20, 2023
Tickers
NVDA
RHHBY
Tags
Market News
Recent Press Releases
NVDA
From
Motley Fool
Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO
December 15, 2023
Tickers
IPO
IPOS
NVO
RHHBY
Tags
News
Briefs
IPOS
From
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in December
December 15, 2023
Tickers
INCY
KNSA
NBIX
RHHBY
Tags
RHHBY
INCY
NBIX
From
InvestorPlace
Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial
December 11, 2023
Tickers
PSTX
RHHBF
RHHBY
RHHVF
Tags
Small Cap
Biotech
Health Care
From
Benzinga
Why Viking Therapeutics Was Crushing It This Week
December 08, 2023
Tickers
NVO
RHHBY
VKTX
Tags
NVO
VKTX
RHHBY
From
Motley Fool
Altimmune’s stock pops as analysts see obesity-drug partnership potential
December 07, 2023
Tickers
ALT
AZN
LLY
NVO
Tags
NVO
LLY
PFE
From
MarketWatch
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
Tickers
ALT
JNJ
LLY
NVO
Tags
Small Cap
Biotech
Large Cap
From
Benzinga
While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
December 05, 2023
Tickers
ALT
MYNZ
PFE
RHHBY
Tags
Penny Stocks
contributors
PFE
From
Benzinga
Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation
December 05, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
Health Care
From
Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
December 04, 2023
Tickers
LLY
NVO
RHHBY
Tags
Ozempic
Jim Cramer
GLP/1 drugs
From
Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
December 04, 2023
Tickers
LLY
NVO
RHHBF
RHHBY
Tags
LLY
NVO
Benzinga
From
Benzinga
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
December 04, 2023
Tickers
ABSI
AZN
NVDA
RHHBY
Tags
Eurasia
Equities
Contracts
From
Benzinga
Ignore Crypto: These Stocks Could Make You Rich
November 23, 2023
Tickers
MDT
NEE
RHHBY
Tags
MDT
Market News
NEE
From
Motley Fool
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
November 17, 2023
Tickers
CLDX
LUNG
PSTX
RHHBY
Tags
LUNG
PSTX
RHHBY
From
InvestorPlace
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
November 16, 2023
Tickers
AZN
BMY
MRK
RHHBY
Tags
RHHBY
General
Briefs
From
Benzinga
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
November 10, 2023
Tickers
BIIB
LLY
RHHBY
Tags
Market News
LLY
BIIB
From
Motley Fool
Regeneron's Skin Drugs Propel Revenue In Q3, Witnesses Strong Demand For Higher Dose Version Of Flagship Eye Drug
November 02, 2023
Tickers
REGN
RHHBY
Tags
Benzinga
Market News
REGN
From
Benzinga
Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
October 31, 2023
Tickers
RHHBF
RHHBY
RHHVF
SRPT
Tags
RHHBF
RHHVF
General
From
Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
Tickers
BHC
CAH
CVS
NVS
Tags
CVS
Penny Stocks
FDA warning
From
Benzinga
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
October 28, 2023
Tickers
LLY
PFE
RHHBY
Tags
Market News
RHHBY
PFE
From
Motley Fool
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
October 24, 2023
Tickers
PFE
RHHBY
ROIV
XBI
Tags
Market News
ROIV
RHHBY
From
Motley Fool
Why Is Roivant Sciences (ROIV) Stock Up Today?
October 23, 2023
Tickers
PFE
RHHBY
ROIV
Tags
Market News
NASDAQ:ROIV,OTCMKTS:RHHBY,NYSE:PFE
Today's Market
From
InvestorPlace
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal
October 23, 2023
Tickers
PFE
RHHBF
RHHBY
ROIV
Tags
PFE
Benzinga
Asset Sales
From
Benzinga
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
October 23, 2023
Tickers
PFE
RHHBY
ROIV
Tags
PFE
ROIV
RHHBY
From
MarketWatch
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
Tickers
BMY
BNTX
PFE
REGN
Tags
Recent Press Releases
BMY
RHHBY
From
Motley Fool
PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
October 19, 2023
Tickers
PTCT
RHHBY
RPRX
SPX
Tags
PTCT
RPRX
RHHBY
From
MarketWatch
Roche Reports Nine Months Sales Growth Despite Lower Sales From COVID-19 Products
October 19, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Biotech
Large Cap
From
Benzinga
What's Going On Cancer Player Monte Rosa Therapeutics Stock Today?
October 17, 2023
Tickers
GLUE
RHHBF
RHHBY
RHHVF
Tags
why it's moving
Briefs
News
From
Benzinga
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
October 17, 2023
Tickers
AZN
BMY
MRK
RHHBY
Tags
AZN
Large Cap
Biotech
From
Benzinga
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
October 16, 2023
Tickers
BMY
NVO
PRTA
RHHBY
Tags
NVO
Trading Ideas
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.